Year 2018 (52)

Edition nr. 9

Drugs to be avoided II

This article is an adaptation of ‘Towards better patient care: drugs to avoid in 2018’, published in our French sister journal Prescrire International, 2018; 27 (192): 107.1-107.9.
  • In view of its unproven efficacy and its potentially serious r ...

Read article

Cardiovascular safety of febuxostat

  • Like patients with diabetes, patients with gout represent, in absolute terms, a large group of patients at clearly increased cardiovascular risk. It is clinically relevant to know the cardiovascular safety of the drugs that they might have to u ...

Read article